Drugs / HL-018
last change Oct 2010 re-read 2 minutes ago

HL-018

Investigated by
Asan Medical Center · HanAll BioPharma Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01232036 May → Aug 2010 Asan Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HL-018 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01232036
Route Oral oral administration” NCT01232036